Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12083099 | 0.89 | ACHE (0.72) | ACHEBCHE | |
| SCHEMBL14866059 | 0.87 | ACHE (0.54) | ACHEBCHE | |
| SCHEMBL10052940 | 0.86 | ACHE (0.55) | ACHEBCHE | |
| SCHEMBL2732498 | 0.83 | ACHE (0.67) | ACHEBCHE | |
| SCHEMBL8827788 | 0.83 | ACHE (0.67) | ACHEBCHE | |
| SCHEMBL8863731 | 0.80 | BCHE (0.72) | ACHEBCHE | |
| SCHEMBL8863723 | 0.80 | BCHE (0.72) | ACHEBCHE | |
| SCHEMBL9539843 | 0.80 | BCHE (0.72) | ACHEBCHE | |
| SCHEMBL9462926 | 0.79 | ACHE (0.67) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL9538512 | 0.79 | BCHE (0.71) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130096316-A1 | Novel Method for Preparation of Bisnorcymerine and Salts Thereof | QR PHARMA, INC. | 2013-04-18 | — | — | US | disclosed |
| US-20130096316-A1 | Novel Method for Preparation of Bisnorcymerine and Salts Thereof | QR PHARMA, INC. | 2013-04-18 | — | — | US | disclosed |
| US-20130096316-A1 | Novel Method for Preparation of Bisnorcymerine and Salts Thereof | QR PHARMA, INC. | 2013-04-18 | — | — | US | disclosed |
| WO-2012058031-A2 | NOVEL METHOD FOR PREPARATION OF BISNORCYMERINE AND SALTS THEREOF | QR PHARMA, INC. (US) | 2012-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096316-A1 | Novel Method for Preparation of Bisnorcymerine and Salts Thereof | PHOSPHO1, CBS, COASY | ACHE 1644/4885BCHE 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.